Results 21 to 30 of about 2,049,261 (287)

Critical illness-induced dysglycaemia : diabetes and beyond [PDF]

open access: yes, 2010
Type 2 diabetes has reached epidemic proportions in many parts of the world. The disease is projected to continue to increase and double within the foreseeable future.
Ann M Sheehy   +11 more
core   +1 more source

Hyperglycaemia increases mortality risk in non‐diabetic patients with COVID‐19 even more than in diabetic patients

open access: yesEndocrinology, Diabetes & Metabolism, 2021
Aim Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐19. We examined the association of hyperglycaemia, both in the presence and absence of pre‐existing diabetes, with severity and outcomes in COVID‐19 patients ...
Jennifer Morse   +7 more
doaj   +1 more source

Incidence and Risk Factors for Glucose Disturbances in Premature Infants

open access: yesMedicina, 2022
Background and Objectives: There are limited data regarding the incidence and risk factors for hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants.
Ivona Butorac Ahel   +6 more
doaj   +1 more source

Glucose Variability [PDF]

open access: yesJournal of Diabetes Science and Technology, 2016
Background: Glucose variability has been suspected to be a major factor of diabetic complications. Several indices have been proposed for measuring glucose variability, but their interest remains discussed.
Le Floch, J, Kessler, Laurence
openaire   +3 more sources

Association of Glucose Variability in the First 72 Hours of ICU Care with ICU Mortality in Critically-III Patients

open access: yesJurnal Penyakit Dalam Indonesia, 2016
Introduction. Hyperglycemia during hospitalization is a risk factor that can be managed in order to reduce mortality. Inspite of hyperglycemia, glucose variability also brings negative outcome to cells.
Elizabeth Yasmine   +3 more
doaj   +1 more source

Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome

open access: yes, 2022
Introduction Cholecystokinin (CCK) is involved in several metabolic pathways, and CCK agonists are considered as a potential novel treatment option in populations with increased metabolic risk, including polycystic ovary syndrome (PCOS).
Andrej Janež   +6 more
core   +1 more source

Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring

open access: yesLibyan Journal of Medicine, 2019
There are no studies evaluating the glucose variability in different periods of Ramadan fasting in patients with type 2 diabetes using continuous glucose monitoring (CGM).
Nesreen Aldawi   +4 more
doaj   +1 more source

Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes

open access: yesFrontiers in Endocrinology, 2021
BackgroundDiabetic nephropathy (DN) is one of the most common microvascular complications in type 1 diabetes Mellitus (T1D). Urinary markers of renal damage or oxidative stress may signal early stages of DN.
Leena Mamilly   +6 more
doaj   +1 more source

Glucose variability and ICU outcome [PDF]

open access: yesCritical Care, 2011
Glycemic excursion or glucose variability (GV) was explored recently as a contributor of mortality, when studies concentrating on strict blood sugar control failed to show consistent results. The objective of this study was to determine the implication of glucose variability on ICU mortality in a heterogeneous ICU population.
Todi, S, Bhattacharyya, M
openaire   +1 more source

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes

open access: yesСахарный диабет, 2019
BACKGROUND: Patients with any form of diabetes during pregnancy should achieve the target (close to physiological) values of glycaemia, the main condition for a safe course and outcomes of pregnancy. To accomplish this task, effective and safe methods of
Alena V. Tiselko   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy